02038nas a2200361   4500000000100000008004100001260000900042653001500051653001000066653000900076653002600085653002300111653001000134653002100144653001100165653002200176653001800198653001100216653002300227653001200250653000900262653001600271653002500287653003100312653001500343653001700358100001400375245004900389300001000438490000700448520120700455022001401662       2007                            d  c200710aAdolescent10aAdult10aAged10aAntitubercular Agents10aBacterial Proteins10aChild10aChild, Preschool10aFemale10aGenome, Bacterial10aGlobal health10aHumans10aLeprostatic Agents10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aMycobacterium tuberculosis10aPrevalence10aTuberculosis1 aHussain T00aLeprosy and tuberculosis: an insight-review.  a15-660 v333 a<p>A quick glance at this review article provides an insight into the common and different features of M. leprae and M. tuberculosis and the diseases caused by these organisms. Table I provides the popular names, history, stigma, description of the disease, clinical features, classification and the types of disease manifestations, who are affected, Signs and Symptoms, Clinical examination, treatment regimens, reactions, relapses, immunity, infectiousness, risk groups, deformities, sequelae, transmission, prevention, complications, vaccination, laboratory studies, days of importance for both the diseases. Table II provides information regarding the causative organisms, M. leprae and M. tuberculosis, their size, genome, protein coding region, lost genes, pseudogenes, classification, predilection, incubation period, ecology, cell structure, metabolism, resistance, bacterial index, growth in vitro, experimental animals, etc. Table III provides figures of M. leprae and M. tuberculosis, their genome, Lepromin and Tuberculin testing, Global scenario, Indian scenario, colonies of M. leprae and M. tuberculosis, drugs for treatment of tuberculosis and leprosy (MDT blister pack), and so on.</p>  a1040-841X